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Social determinants of 'health' of embryos 
ways to characterize the health of children and adults, including persons living with dis-
abilities and those not yet born with disabilities. Following this discussion is an exploration 
of the differences between social determinants of embryo health that affect the biomedical 
health of children, and biomedical determinants of embryo health that are directed towards 
enhancing the perceived social health of children and their parents. Finally, we examine the 
implications of different concepts of health on determinations of the health of embryos, 
children and adults. Throughout this chapter, we locate considerations of the health of the 
embryo as social practices, existing in political, economic and social contexts, and we 
acknowledge that norms and values about child and adult health infuse determinations of 
embryo health and vice versa. 
Biomedical determinants of the 'health' of embryos 
In genetics laboratories, determinations of extra chromosomes or absent chromosomes, as 
well as deletions, additions and translocations of parts of chromosomes are made through 
viewing photomicrographs and other representations of chromosomes (Melotte, Debrock, 
D'Hooghe et at., 2004), frequently enhanced by fluorescent in situ hybridization (FISH) 
(Delhanty, Griffin, Handyside et at., 1993). Detection of markers for an increasing number 
of genetic conditions (Verlinsky, Rechitsky, Sharapova et at., 2004; Marchini, Donnelly and 
Cardon, 2005) are made through determinations of specific DNA sequences after their 
amplification by polymerase chain reaction (PCR) (Mullis and Faloona, 1987). In 2004, 
PCR determinations of the health of embryos were reported for more than 300 genetic 
conditions (Verlinsky, Rechitsky, Sharapova et at., 2004). 
Preimplantation genetic diagnosis (PGD) allows biomedical determinations of embryo 
health to be made from a single cell from an in vitro fertilization (IVF) embryo (Handyside, 
Kontogianni, Hardy et at., 1990), instead of through amniocentesis at 16 weeks gestational 
age (Serr, Sachs and Danon, 1955) or chorionic villus sampling (CVS) a few weeks earlier 
(Neilson and Alfirevic, 2006), obviating the need for consideration of abortion for genetic 
reasons (Nisker and Gore-Langton, 1995). However, PGD requires the woman to accept the 
risks of harm from IVF drugs (Abramov, Elchalal and Schenker, 1999), surgery (Alsalili, 
Yuzpe, Tummon et at., 1995), and a decreased chance of becoming pregnant (Nisker and 
Gore-Langton, 1995; Mastenbroek, Twisk, Echten-Arends et at., 2007). IVF clinics are 
increasingly employing 'routine screening' of IVF embryos or polar bodies for chromo-
somal anomalies to avoid both miscarriages (Verlinsky, Rechitsky, Sharapova et at., 2004) 
and children 'affected' by irregular chromosome patterns. 
In IVF laboratories prior to the advent of embryo cryopreservation (Trounson and Mohr, 
1983), microscopic determinations of embryo health, including evidence of cell division, lack 
of fragmentation and blastomere symmetry and clarity, were undertaken in an attempt to 
determine the three (or more) 'best' or 'most suitable' embryos to transfer to the woman's 
uterus, with the remaining embryos discarded to avoid high-order multiple pregnancy 
(Lornage, Chorier, Boulieu et at., 1995; Van Voorhis, Grinstead, Sparks et at., 1999; 
Soderstrom-Anttila, Foudila, Ripatti et at., 2001; Newton, McDermid, Tekpetey et at., 2003; 
Nisker, White, Tekpetey et at., 2006). For the past 15 years, embryos not transferred in the 
IVF treatment cycle have been cryopreserved for later transfer to the woman so that she may 
avoid the harms of additional IVF cycles (Alsalill, Yuzpe, Tummon et at., 1995; Abramov, 
Elchalal, and Schenker, 1999). 
The purpose of making a biomedical determination of the health of an embryo may 
alter perceptions of the health or suitability of embryos. For example, if the purpose of a  
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An increasing focus on the biomedical determinants of the health of embryos and fetuses is 
resulting from new technical possibilities, clinical considerations and research purposes 
(Nisker and White, 2005), but also from social factors, and for a variety of reasons. An 
exploration of the determinants of health of embryos, just as an exploration of the deter-
minants of child or adult health, must take into consideration traditional social deter-
minants, including those related to the consequences of poverty, such as poor nutrition and 
toxic environments (World Health Organization, 1948; Wilkinson and Marmot, 2003; 
Raphael, 2004), but also laws, policies and institutions, which are also social determinants 
of health (Wilkinson and Marmot, 2003). 
The increasing focus on determining the biomedical health of embryos or fetuses may 
have profound effects on the concept of health, not only as applied to these entities but as 
applied to existing children and adults. Conversely, concepts of both the biomedical and 
social health of children and adults may have profound effects on concepts of the bio-
medical and social health of embryos and the development of strategies to make such 
determinations. Accepting a purely biomedical concept of health empowers certain people 
and institutions with the ability to define health and manage healthcare, while simultan-
eously excluding others (Lippman, 1988). 
We will use the term 'embryo health' in the understanding both that terms such as 
'pre-embryo' (Handyside, Kontogianni, Hardy et at., 1990; Nisker and Gore-Langton, 1995; 
Spallone, 1996), 'embryo' and 'fetus' represent a continuum of cell divisions and differenti-
ations, and that attempts to construct distinctions based on time from fertilization are artificial 
and often derived for vested purposes and interests (Spallone, 1996; Fox, 2000; Post, 2003). 
However, we acknowledge that in some circumstances, an embryo and viable fetus should be 
viewed differently. Although not a person, the human embryo is a social entity (Duden, 1993; 
Franklin, 1997), and making determinations about the health of an embryo is always a socially 
informed process. Discussions about determinants of the health of the embryo must include 
both the in vitro and in vivo embryo, as well as the purposes for determining its health. 
We explore the concept of embryo health by first examining the biomedical deter-
minants of health under which embryos may be scrutinized and the purposes for which 
such biomedical determinations are made. We then examine the traditional social deter-
minants of child and adult health and their relation to embryo health. Next we explore the 
effect of biomedical and social determinants of the health of embryos on constructing new 
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determination is to prevent having a child who would develop an X-linked recessive 
condition, the health of an embryo with a Y chromosome is viewed differently than if the 
purpose of the determination is to select the gender of a child for social reasons. Similarly, 
when identifying a DNA sequence associated with deafness (Levy, 2002) or dwarfism (Saito, 
Sekizawa, Morimoto et al., 2000; Nunes, 2006), whether the purpose of the deterixination is 
to prevent giving birth to a child who is deaf or of short stature or to purposefully have a 
child with such a characteristic determines how the DNA sequence is viewed. Another 
example of how the same biomedical determinant of embryo health may be viewed dif-
ferently because of its purpose is the testing an embryo for its suitability (after birth) to be a 
stem cell 'donor' for an ill child (Pennings, Schots and Liebaers, 2002; Verlinsky, Rechitsky, 
Sharapova et al., 2004). For this purpose, embryos that would be seen as healthy and 
suitable for implantation based on biomedical determinations made for any other purpose, 
but are determined not to be histocompatibly suitable for stem cell 'donation' to the in 
child, are discarded (please refer to Sheldon and Wilkinson, Chapter 17). 
Research purposes may also alter perceptions of the biomedical health of embryos. For 
example, some stem cell researchers believe that 'fresh' embryos are preferable to cryo-
preserved embryos (donated after the woman no longer requires them for her reproductive 
purposes) for their purpose (Nisker and White, 2005). This preference has encouraged a 
recent revival of interest in microscopic determinants of the health of IVF embryos, and 
those embryos determined as likely to be unhealthy or unsuitable are 'donated' 'fresh' to 
stem cell research (Nisker and 'White, 2005; Nisker, White, Tekpetey et al., 2006; McLeod 
and Baylis, 2007). No evidence exists that an embryo's potential to become a child can be 
completely ruled out until it stops dividing and degenerates (Newton, McDermid, Tekpetey 
et al., 2003). In Australia, where until recently, all additional IVF embryos were viewed as 
having the capacity to be healthy, no 'fresh' embryos were donated to research (Nisker, 
White, Tekpetey et al., 2006). However, in response to a desire of Australian stem cell 
researchers to use 'fresh' embryos for their research purposes, a recent National Health and 
Medical Research Council guideline (National Health and Medical Research Council 
[NHMRC], 2007) describes morphologic criteria by which embryos may be declared less 
healthy or less suitable and thus can be 'donated' 'fresh' to stem cell research. 
Social determinants of the 'health' of embryos 
The concept of social determinants of health emerges from the World Health Organization 
(WHO) definition of health (World Health Organization, 1948) and recognizes that eco-
nomic and social conditions influence the health of individuals and communities (Raphael, 
2004). These social determinants include factors such as ethnicity, community structure, 
economics and law (Frazee, Gilmour and Mykitiuk, 2002; Siegler and Epstein, 2003), as well 
as education, employment, working conditions, nutrition, healthcare services, transporta-
tion, housing, income and social inclusion (Hofrichter, 2003; Raphael, 2004). A social 
determinants approach reveals the ways in which health is dynamically produced within 
specific social environments and political contexts and by culturally informed perceptions 
of an individual's bodily experiences and functions (Krieger, 2005). 
Many of the social determinants of health considered important for the biomedical health 
of children and adults may also be important determinants of the biomedical health of 
embryos. For example, poverty and its related social determinants of health, such as poor 
nutrition, toxic environment and infectious diseases can, when related to the health of women, 
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both prior to and during pregnancy, become social determinants of health of the embryo. 
Social determinants of health of embryos, such as malnutrition (Stanner, Bulmer, Andres 
et al., 1997; Eriksson, Forsen, Tuomilehto et al., 1999; Roseboom, Van Der Meulen, Osmond 
et al., 2000; Montgomery and Ekbom, 2002; Plagemann, Rodekamp and Harder, 2004) 
including folic acid deficiency (Koren, 1993), and toxic environment (Peakall, Hallett, Bend 
et al., 1982; Jarrell, Gocmen, Foster et al., 1998) can result in biomedical impairments for the 
children they become. Poverty during pregnancy is associated with an increased incidence of 
smoking (Quinton, Cook and Peek, 2008), alcohol consumption (Koren, 1991), and drug 
addiction (King, 1997), all of which affect the embryo and could result respectively in fetal 
hypoxemia (Socol, Manning, Murata et al., 1982; Ng and Zelikoff, 2007), fetal alcohol syn-
drome (Centers for Disease Control and Prevention [CDC], 2004; Chudley, Conry, Cook 
et al., 2005), and crack cocaine syndrome (Singer, Minnes, Short et al., 2004). Maternal poverty 
is also related to an increase in viral infections and other pathogens, which, when present 
during pregnancy, may affect the health of the embryo and eventually the health of the child 
that embryo may become (Goldenberg, Hauth and Andrews, 2000; Feigin, 2005). 
These social determinants of embryo health can also have long-range effects on the 
biomedical health of the adults the embryos become (generally referred to as the 'Barker 
Hypothesis') (Barker, 1992). Research on a cohort of adults whose mothers were pregnant 
with them during the Dutch famine from 1944 to 1945 indicated that nutritional depriv-
ation of pregnant women resulted in coronary artery disease in their offspring 50 years later 
(Roseboom, Van Der Meulen, Osmond et al., 2000). Further, studies have shown an 
association, particularly in animals but also in humans, of nutritional deprivation and other 
factors, not only in coronary artery disease (Eriksson, Forsen, Tuomilehto et al., 1999; 
Roseboom, Van Der Meulen, Osmond et al., 2000), but in type II diabetes (Stanner, 
Bulmer, Andres et al., 1997; Ravelli, Van Der Meulen, Michels et al., 1998; Montgomery 
and Ekbom, 2002; Plagemann, Rodekamp and Harder, 2004). 
Another social determinant of the biomedical health of the embryo is that women 
are delaying becoming pregnant (Nybo Andersen, Wohlfahrt, Christens et al., 2000; 
Hammarberg, Clarke, Tough et al., 2002), a factor that is conditioned by social and cultural 
contexts. Delaying pregnancy is increasingly common (most often in developed nations) for 
a variety of social reasons (Gosden and Rutherford, 1995; Hammarberg and Clarke, 2005; 
Nisker and Bergum, 2007), including pursuit of education, career and financial inde-
pendence and being in a committed relationship. Because older women have an increased 
susceptibility to giving birth to children with chromosomal aneuploidy (Heffner, 2004; 
Society of Obstetricians and Gynaecologists of Canada [SOGC], 2007; Summers, Langlois, 
Wyatt et al., 2007), they are more likely to undergo amniocentesis (American College of 
Obstetricians and Gynecologists [ACOG], 2001), chorionic villous sampling (Neilson and 
Alfirevic, 2006), or PGD (Berkowitz, Roberts and Minkoff, 2006), thus exposing their 
embryos and fetuses to biomedical determinations of genetic 'health.' Women who delay 
childbearing are also susceptible to infertility due to oocyte depletion (Pastor, Vanderhoof, 
Lim et al., 2005), recurrent miscarriages (Benzies, 2008), endometriosis (Mishell, 2001), and 
fallopian tube damage (Mishell, 2001), and are thus more likely to undergo IVF, which 
exposes their embryos to a variety of biomedical determinants. 
The association of advanced age and infertility has resulted in an increase in the use of 
fertility drugs, which can lead to an increase in multiple pregnancies and in children born 
prematurely (Drack, 1998; Barrett and Bocking, 2000; Elster, 2000; Adamson and Baker, 
2004; Inder, Warfield, Wang et al., 2005). These children have a preponderance of ______ 
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long-term health problems (Drack, 1998; Barrett and Bocking, 2000; Elster, 2000; Adamson 
and Baker, 2004; Inder, Warfield, Wang et al., 2005). If the social and economic factors 
leading to infertility were addressed so that women could be having children earlier and 
could be subject to fewer internal and external environmental 'causes' of infertility (Hull, 
Glazener, Kelly et al., 1985; Thonneau, Marchand, Tallec et al., 1991), the 'need' for IVF 
would be reduced along with the corresponding problems relating to embryb 'health'. One 
solution is to direct resources to infertility prevention strategies, such as reducing the 
incidence of sexually transmitted diseases, investing in changing the social conditions and 
correcting environmental conditions that contribute to infertility. 
Although the fact of gestation focuses our attention on the relationship between 
maternal health and that of the embryo, paternal exposure to environmental and occupational 
toxins may, through genetic mutations in sperm, also affect the health of embryos, including 
those that become children (Singh, Muller and Berger, 2003; Thacker, 2004; Rubes, Selevan, 
Evenson et al., 2005; Zini and Libman, 2006). A relationship has been observed between 
embryo health and paternal smoking, drug use and alcohol use (Rubes, Selevan, Evenson 
et al., 2005; Zini and Libman, 2006). Further, men who are addicted to drugs or alcohol help 
to create a social environment that can harm maternal and embryo health. For example, 
male partners may encourage or pressure pregnant women to continue to use alcohol or 
drugs (Chavkin, Paone, Friedmann et al., 1993). In addition, drug or alcohol addiction on 
the part of women, including those who are pregnant, is often a coping mechanism for 
dealing with the trauma of sexual and other forms of abuse (Silverman, Decker, Reed et al., 
2006). Pregnant women are more likely than non-pregnant women to be victims of 
domestic abuse (SOGC, 2005). 
Economic factors are also social determinants of health (World Health Organization, 
2005). Particular to embryo health, economic factors include allocation of resources to 
improve the social determinants of maternal and embryo health. Economic factors also 
facilitate access to the procedures that place embryos under DNA or microscopic lenses, as 
well as influencing the purpose for which they are placed under the lens. In some countries, 
economic factors allow some prospective parents to make determinations of embryo health, 
thus empowering some individuals, but not others, to make personal choices about genetic 
risk. In a social context that does not adequately support and accommodate people with 
impairments and their families, decisions about using PGD, amniocentesis or CVS to assess 
embryo health may be influenced by the perceived economic and social costs of having a 
genetically 'unhealthy' child. 
The economic factor of low income predisposes some women in Canada and the United 
States to use fertility drugs without the safety of IVF and single embryo transfer, resulting 
in an even greater risk of multiple pregnancy and its consequences (Min, Claman and 
Hughes, 2006; Mykitiuk and Nisker, 2008). Equal access to IVF as exists in many European 
countries and Australia would decrease the impact of the social determinant of low income 
and its biomedical effects. However, IVF and fertility drugs may have long-term health 
effects on the child and adult that embryo may become, particularly in relation to 
Angelman syndrome (Cox, Burger, Lip et al., 2002; Orstavik, Eiklid, van der Hagen et al., 
2003) and Beckwith-Wiedemann syndrome (DeBaun, Niemitz and Feinberg, 2003; Maher, 
Brueton, Bowdin et al., 2003). 
Further, any economic arguments must consider the financial costs of caring for pre- 
mature neonates in the neonatal intensive care unit, as well as the care required to assist the 
F 
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children that survive with 'disabilities' (Barrett and Bocking, 2000; Gilbert, Nesbitt and 
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Danielsen, 2003; Phibbs and Schmitt, 2006; Nisker, 2008). The economic factors that 
influeiice who can access IVF, PGD, amniocentesis and CVS, and for what 'conditions' 
inform and are informed by prevailing conceptions about what health is, which in turn are 
products of social ideologies, institutions and decisions about the allocation of resources. 
Regulation is also an important social determinant of health. The law establishes the role 
of the state in relation to improving health (Siegler and Epstein, 2003; Krieger, 2005), as 
well as creating and shaping the conditions within which health can be achieved (Frazee, 
Gilmour and Mykitiuk, 2002). Further, regulation plays an important role in shaping what 
we view as health, including the characterization of the health of embryos. Although a legal 
examination of what constitutes a healthy embryo is beyond the scope of this exploration, it 
should be noted that no jurisdiction has a comprehensive regulatory framework (such as a 
Healthy Embryo Act) that defines what a healthy embryo is and the conditions within which 
to achieve it. Rather, in Canada, the United Kingdom, Australia, New Zealand, France and 
Germany, an array of statutes, regulations, policy and case law form a corpus of juris-
prudence about the embryo that examines a range of issues, including the legal status of the 
embryo; the legal consequences of harm to a fetus or embryo; judicial intervention into 
pregnancy; and the regulation of embryo research, creation, destruction, disposition and 
donation. 
Although law exists pertaining to embryos and fetuses, we found scant reference to the 
health (and cognates) of an embryo or its ill health (and cognates). Moreover, in no 
legislative documents are any of these terms when used in relation to an embryo, ever 
defined. Thus, the legal conception or definition of health in relation to the embryo is most 
often a matter of judicial interpretation, often relating to the ultimate utility or purpose of 
the embryo. Indeed, even the legal definition of the terms 'embryo' and 'fetus' shift among 
jurisdictions and contexts (Fox, 2000). 
A social determinants approach demonstrates that responsibility for embryo health 
rests not only on individual women but is shared with men, public institutions and social 
structures. For example, poor nutrition, toxic environments (including workplaces), drug 
and alcohol use, and poverty and violence, when mediated through the bodies of pregnant 
women, are all profoundly social determinants of embryo health. Inadequate social 
structures and social exclusion also have consequences, such as poverty, lack of education, 
poor employment, and poor healthcare, all of which can contribute to maternal or 
paternal behaviours and, through them, to poor embryo health (please refer to Karpin, 
Chapter 10). 
A social determinants approach to embryo health requires us to attend to the social 
environments in which women, men and embryos exist, rather than locating health and 
illness exclusively within the individual body 
- be it an embryonic body or that of a 
person. This role of social environments is important to acknowledge, especially when 
biomedical assessments of embryo health are increasingly focused on embryos that have 
been created outside of women's bodies but are dependent on women's embodiment for 
gestation and birth. Optimizing the health of all embryos, not just those created by IVF, 
requires that we attend to the maternal and paternal 'environment' as a determinant of 
health of the embryo. Concern about the maternal environment itself requires us to care 
for and about the pregnant woman (i.e. ensuring adequate nutrition and prevention of 
exposures to toxins in the environment and workplace), because through her, embryo 
health is affected. In a social determinants approach, the health effects on the embryo are 
'socialized' and not just 'individualized'. 
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Interwoven implications of determinants of the health 
of embryos, children and adults 
Just as biomedical and social determinants of the health of an embryo are informed by ideas 
and evaluations of the characteristics of the child that embryo may become, as well as 
concepts of 'health', 'disease', 'illness', 'well-being' and 'disability' in children and adults, 
determinations of embryo health have implications for our perceptions of the social and 
biomedical health of children and adults. Biomedical and social determinants of embryo 
health share the assumption that the condition of health can not only be identified in 
embryos but that such a determination is important when considering the health of chil-
dren and adults. Although the means and conditions through which health is determined 
and produced differ with biomedical and social approaches, health is construed by each as a 
goal worthy of pursuit and funding. Implicit in both biomedical and social determinants of 
health is the idea of an optimal, or at least preferred, normative concept of health and the 
possibility of making positive and negative evaluations of health. Therefore, we must attend 
to the criteria, both factual and normative, through which we assess the biomedical and 
social determinants of the health of embryos, and consider how such determinations are 
and ought to be made and the impact of such determinations of health on current and 
future children and adults. 
Common to many understandings of health are the notions of absence of illness or 
disease and the normative functioning of biological systems (Woibring, 2005). With these 
understandings, the aim of medicine is to prevent, diagnose and treat disease and illness. 
When an anomalous characteristic in morphological, functional or genetic make-up is 
detected, medicine aims to restore to 'species-typical functioning' the person who has lost 
her perceived biological health because of unfavourable biomedical or social determinants 
(Buchanan, Brock, Daniels et al., 2000), which is achieved through treatment, rehabilitation 
or management of the impairment. 
In the case of an embryo, to prevent the person born of a specific embryo from 
exhibiting disease, disability, impairment or sub-normative functioning, either discarding 
the embryo or performing an abortion is required (Buchanan, Brock, Daniels et al., 2000), 
except in rare situations where strategies for correction can be employed during pregnancy 
or following birth, such as fetal surgery for open neural tube defect (Botto, Moore, Khoury 
et al., 1999) or cardiac anomaly (Harrison, 1996). Thus, rather than biomedical deter-
minations of embryo health being strategies for preventing ill health (Steinbock, 2000; 
Shakespeare, 2006), they are generally techniques for selection (Asch, 2000; Parens and 
Asch, 2000; Asch, 2003; Asch and Wasserman, 2005). Alternatively, prevention of the 
impairment in the person whom that embryo may become can be achieved by improving 
social determinants of maternal health, such as better maternal diet, increasing the intake of 
folic acid, or reducing alcohol consumption (please refer to Karpin, Chapter 10). 
The exponential increase in research funding in genomics will probably result in the 
identification of a genetic contribution to many human differences. How these differences are 
interpreted, placed into context, and acted upon could have social implications for current and 
future persons. In addition, genomics research will create new biomedical and social deter-
minants of embryo health, which could in turn have implications on the perceived health of 
children and adults. For example, the differences in the DNA sequences in the genotypes of 
'healthy-appearing persons are called 'polymorphisms'. However, when a polymorphism is 
correlated with a particular 'phenotype' (observable expression of genotype), it becomes a 
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'mutation' (Gerald Kidder, personal communication, 2005). Once a DNA sequence is termed a 
'mutation', embryos with this mutation may be viewed as unhealthy and then become the 
targets of the new clinical purpose of preventing individuals having these mutations through 
the use of PGD. Further, because the word 'mutation' could have a pejorative connotation, once 
the correlation between a genetic polymorphism and a particular phenotype is determined, 
children and adults with previously considered anomalous characteristics become children and 
adults with mutations, and could be viewed differently. However, the detection of a marker for 
a mutation does not alter the health of the potential child. Further, because the phenotypic 
expression of a gene may vary considerably (Morley, Molony, Weber et al., 2004), and social 
determinants, such as education, family and government support, could greatly moderate the 
impact of the presence of an anomalous characteristic, whether or not a correlation with a 
mutation is known. 
Social responses to the characterization of a trait as a mutation rather than a variance may 
have a profound impact on the social health of a child carrying a mutation. For example, the 
social perception and treatment of a child with 'attention deficit syndrome' may be dra-
matically altered if a mutation for this condition is discovered, thereby turning a learning 
difference into a genetic condition that could be 'prevented'. A child with a genetic mutation 
may be viewed differently from a child who may require specific social and educational 
services and accommodations. Children resulting from embryos with a mutation that could 
have been genetically tested and discarded may be looked upon as 'drains' on educational and 
social welfare systems, and their parents may be viewed as irresponsible for not preventing 
such drains (Rothman, 1986; Nisker and Bergum, 1999; Mykitiuk, 2002; Nisker and Bergum, 
2007). Further, all children with learning-specific needs may eventually be looked upon as 
having a disease for which a gene mutation has not yet been found, rather than as individuals 
exhibiting characteristics within the wide and diverse range of human attributes. 
As more biomedical determinants of embryo health become available to scrutinize indi-
cators of the 'qualities' and characteristics of the prospective child, particularly those qualities 
that are socially valued and desired, social values and preferences about personal characteristics 
could become conflated with the health of the embryo. Giving social preferences a medical 
status, through their biomedical determinations in healthcare facilities and frequently through 
public funding, not only masks the fact that they are merely social preferences but simultan-
eously detracts attention and resources from the actual social determinants of health of embryos 
and children. For example, prospective parents who believe their child's social health and well-
being are determined by factors related to enhanced cognitive capacity have, for more than 30 
years, been creating embryos through the purchase of sperm from genius sperm banks (Flint, 
2006). Similarly, prospective parents who believe their child's social health or well-being is 
determined by physical appearance can bid for the oocytes of 'Ron's Angels', 'models' whose 
photographs and other descriptors appear on the Internet (Nisker, 2001, 2002; Harris, 2003). 
Such attempts to enhance a child's social health and well-being may also inform uses of PGD to 
detect or select for qualities in the embryo, further calling into question the bases upon which 
determinations of embryonic and child health are made. 
Determinations- 
 of embryo health are informed not only by concerns about the bio-
medical and social health of the child who may be born from that embryo, but consider-
ations of the social health and well-being of third parties. For example, prospective parents 
may perceive their social health to be determined, or at least influenced, by having a 
'healthy' child, or a child with specific characteristics, thereby justifying their use of tech-
nology to determine the biomedical health of the embryo. This perception could be shared 
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by potential parents who feel that they do not have the physical, emotional, social or 
financial resources to care for a child with a genetic 'condition', and potential parents who 
knowingly or unknowingly want to enhance how others view them by enhancing physical 
and cognitive characteristics of their children. 
The use of PGD to select for genetic traits perceived by many to be associated with ill 
health or impairment, such as deafness (Levy, 2002; Savulescu, 2002), raises additional issues 
regarding the relationship between embryo health and that of children and adults. Just as 
lesbian members of the deaf community have used donor sperm (Levy, 2002; Savulescu, 2002) 
to increase their chances of having a child who is deaf, a couple seeking to use PGD to have a 
child who is deaf may be acting in an analogous manner to prospective parents who are legally 
allowed to access biomedical determinants to promote in their children the qualities they 
associate with social health. However, in New Zealand, the Guidelines on Preimplantation 
Genetic Diagnosis 2005 prohibit the use of PGD for the selection of 'embryos with a genetic 
impairment seen in a parent'. In Australia, Victoria's Infertility Authority has also specifically 
prohibited 'the use of PGD to select in favour of genetic disease or abnormality on the basis 
that it would be inconsistent with the first guiding principle of their Act: 'the welfare and 
interests of any person born or to be born as a result of a treatment procedure are para-
mount'. In both countries, the legislation justifies the prohibitions according to the need to 
protect and ensure the best interests, well-being and health of children born as a result of 
PGD (neither piece of legislation, however, defines health) (Van Wagner, Mykitiuk and 
Nisker, 2008). However, it could be argued that such legislation regarding embryos may cause 
children and adults who are deaf to be seen as having a disease worth preventing (as well as 
not selecting for) (please refer to Sheldon and Wilkinson, Chapter 17). 
The use of PGD to select embryos for the purpose of becoming a stem cell 'donor' (after 
birth) for an ill sibling serves as an example of third-party interest, as well as a model to 
further explore the concept of the health of an embryo and its relationship to the health of a 
child. In the situation of selecting an embryo to be a child who can be a stem cell donor (a 
'saviour sibling'), embryos that are healthy according to biomedical determinants but lack 
the histocompatibiity characteristics consistent with being a stem cell donor are discarded, 
as are embryos with markers for the ill child's genetic condition (Verlinsky, Rechitsky, 
Sharapova et al., 2004). 
In the United Kingdom, the use of PGD was permitted to select for an embryo to be a 
stem cell 'donor' (histocompatibiity matched) for an ill sibling with an inherited condition 
(Human Fertilisation and Embryology Authority, 2001; Dyer, 2002), while in another case, 
the use of PGD for the purpose of selecting embryos for stem cell 'donation' was refused 
because the ill child did not have a genetic mutation for an inherited disease (Hall, 2002; 
Gavaghan, 2004; Sheldon and Wilkinson, 2004). In the former case, PGD was permitted to 
avoid having a child with a serious inherited disease of which the family was at risk, and 
thus performing PGD would constitute a health benefit to the child who developed from the 
embryo that had been screened, making it possible to prevent the birth of a child with a 
genetic condition. However, in the latter case 'the legal condition of allowing PGD to avoid 
serious disease was not applicable' (Bellamy, 2005) because the embryo was not at risk of 
having a gene for an inherited condition, and 'selection for an HLA [human leukocyte 
antigen] match alone would have no diagnostic and preventive function and would, 
therefore, set a new precedent of PGD being used solely for the purpose of creating 
offspring with specific desired traits' (Franklin and Roberts, 2006, p.  65) (please refer to 
Sheldon and Wilkinson, Chapter 17, for the current situation in the United Kingdom). 
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A similar logic animates the New Zealand Guidelines on Preimplantation Genetic 
Diagnosis (National Ethics Committee on Assisted Human Reproduction, 2005) that 
restricts PGD for HLA tissue typing to situations where there are 'therapeutic indications 
for the embryo to justify embryo biopsy (Human Genome Research Project, 2006; Van 
Wagner, Mykitiuk and Nisker, 2008). This policy permits tissue typing where both the live 
child who would be the recipient of the transplant and the embryo are at risk of being 
affected by a 'familial single gene disorder or a familial sex-linked disorder' (National Ethics 
Committee on Assisted Human Reproduction, 2005, p.  6). 
Restricting PGD to cases in which the 'embryo may benefit' (Gavaghan, 2004; Sheldon 
and Wilkinson, 2004) or have a 'therapeutic indication' (Human Genome Research Project, 
2006) is problematic as an embryo cannot 'benefit' from the removal of a blastomere or 
blastocyst tissue (and its genetic testing), nor can a 'therapeutic intervention' occur for an 
embryo, although fetal surgery is sometimes a possibility for anomalies such as those related 
to the cardiovascular and neuroskeletal systems (Harrison, 1996; Botto, Moore, Khoury et al., 
1999). Rather, the 'benefit' or 'therapeutic indication' implied in the United Kingdom and 
New Zealand examples is the destruction of the embryo: the antithesis of both a 'benefit' and 
a 'therapeutic indication' for that embryo. PGD does not provide a benefit to the embryo that 
is found not to have a genetic marker or the future child resulting from that embryo because 
the health of the future child is in no way improved by PGD. Rather, these embryos that are 
found not to carry a genetic marker have a slightly decreased chance of becoming a child 
because of the PGD process (Mastenbroek, Twisk, Echten-Arends et al., 2007). The 'benefit' 
of PGD in these circumstances accrues not to the tested embryo but to third parties: the ill 
sibling who has a 'therapeutic indication' and her parents. Although the Human Fertilisation 
and Embryology Authority (HFEA) has recently overturned its decision regarding not per-
mitting PGD unless the ill child has an inherited condition (Bellamy, 2005), the New Zealand 
guidelines remain in effect (please refer to Sheldon and Wilkinson, Chapter 17). 
Determining the biomedical health of an embryo can have implications for the biomedical 
health of adults through testing embryos for genetic markers for adult-onset conditions such 
Huntington's disease (Hayden, Bloch and Fahy, 1988), BRCA-gene breast cancer (Narod, 
Feunteun, Lynch et al., 1991; Narod, Lynch, Conway et al., 1993) and, most recently, Alzheimer's 
disease (Verlinsky, Rechitsky, Verlinsky et al., 2002). Although an embryo carrying a gene 
marker for one of these conditions would result in a person that would likely live 40 years before 
the genetic condition expresses itself, because of the capacity to determine these gene markers, 
embryos that would have previously been considered healthy may now be considered unhealthy. 
In addition, although an embryo that is determined to have a genetic marker for Huntington's 
disease is almost certain to result in a person who will eventually develop the disease (Myers, 
2004), a person born from an embryo with a marker for a BRCA gene mutation has a much 
lower chance of developing breast cancer (except for Ashkenazi Jewish women who have up to 
an 80% chance) (Narod, Madlensky, Bradley et al., 1994), whereas a person born from an 
embryo that was determined to have a gene marker for Alzheimer's disease is even less certain to 
develop the disease. 
The implications of different concepts of health on 
determinations of the health of embryos, children and adults 
Interpretations of the concept of health have implications for biomedical and social 
determinations of the health of embryos, children and adults. Contrary to the common 
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structures and function of the individual's body and mind (often understood as impair-
ments) and the contextual factors of the environment in which the person lives (e.g. legal 
and social structures, social attitudes, architectural structures) as well as personal factors 
(e.g. gender, age, education) (World Health Organization, 2001). According to the ICF 
scheme, body functions and structure are divided into a number of domains, while activities 
and participation are described in the domains of learning and applying knowledge; general 
tasks and demands; communication; mobility; self-care; domestic life; interpersonal inter-
action and relationship; major life areas; and community, social and civic life. The term 
'functioning' refers to all body functions, activities and participation, whereas 'disability' is an 
umbrella term for impairments, activity limitations and participation restrictions. Environ-
mental and contextual factors interact with all of these components (World Health Organ-
ization, 2001) and include products and technology; the natural and human-made changes to 
the environment; support and relationships; attitudes and services; and systems and policies 
(World Health Organization, 2001). 
The ICF classification treats all of these dimensions as interactive and dynamic and is 
neutral as to aetiology, placing the emphasis on function rather than condition or disease. 
What matters are the activity limitations and/or participation restrictions (if any) experi-
enced by the person with the disease, condition or impairment, and the means by which 
such restrictions may be ameliorated. Activity limitations and participation restrictions can, 
in most cases, be remedied by assistive devices, anti-discrimination laws, and education, 
and, in some cases, by surgery and other forms of medical intervention. 
Understanding health, disability, and functioning along the lines of the ICF renders 
problematic the use of morphological characteristics and genetic markers to assess embryo 
health, especially in contexts where they are intended to determine the health of the person 
that embryo may become. Indeed, biomedical determinants of embryo health reinforce a 
medicalized and diminished model of health and disability that runs counter to the 
understanding of health and disability that informs much law and social policy (Eldridge v. 
British Columbia, 1997; Granovsky v. Canada, 2000). This uncritical reliance on a single 
characteristic in the embryo 'dominates the judgment of its life prospects' and 'reproduces the 
stigmatization of people with disabilities at the level of reproductive choice' (Wasserman, 
Bickenbach and Wachbroit, 2005, p.  14). 
Western Australia's Reproductive Technology Council (RTC), responsible for assessing 
applications for PGD, invokes the ICF criteria for the health of children and adults in its criteria 
for evaluating the 'risk and seriousness of the condition to be tested for' (Reproductive 
Technology Council, 2004), using some language that is identical to the ICF, including the 
family's 'experience with, and attitude to' the condition; the 'level of impairment to body 
functions and structures that is usually associated with a condition; the difficulties expected in 
'participating in activities such as learning and applying knowledge, communication, mobility, 
self care, employment, community, social and civic life'; the 'level of support' required and the 
'capacity of the family' to provide it; and the 'prospects for new and longer term treatments 
and interventions for the condition' (Reproductive Technology Council, 2004). Although the 
RTC document refers to the 'embryo', determinations of 'a significant risk of a serious genetic 
abnormality or disease' in the embryo are contingent on views about the health of the child 
that embryo might become. However, a comprehensive evaluation of the social context in 
which the child will live part of any consideration for PGD, and even if such an evaluation is 
attempted as directed by the RTC, one cannot determine the level of health, disability and 
functioning of the potential child. Although PGD maybe able to detect a marker for a genetic 
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biomedical concept of health, variation from 'species-typical functioning' (Buchanan, 
Brock, Daniels et al., 2000) is not necessarily an indication of ill health because health is 
determined socially as much as it is biomedically (Davis, 1995; Taylor and Mykitiuk, 2001; 
Amundson, 2005; McMahon, 2005; Thomas, 2007). Biomedical differences or deviations 
from statistical 'norms' are often only indicators of poor health when declared so within a 
social context (Davis, 1995, 2002; Taylor and Mykitiuk, 2001). 
Just as interpretations of the concept of health have implications for biomedical and social 
determinations of the health of embryos, children and adults, interpretations of the concept 
of health have implications for the meaning of 'disabiliy (Frazee, Gilmour and Mykitiuk, 
2002; Woibring, 2005; Thomas, 2007). Commonly 'disability refers to "limited activity" - not 
being able "to do things", and a "disabled person" is someone who has a medically certifiable 
"condition" that prevents him or her carrying out the full range of age-related activities 
considered normal' (Thomas, 2007, p. 12). This perspective 'assumes that an injury to the 
body - through illness, accident or "developmental abnormalities" in gestation - is the cause 
of disability' (Thomas, 2007, p. 12). Disabled people as a group are often regarded as patients 
who are unhealthy, where health is associated with a relationship to disease and illness and 
rarely with social health or well-being. Most often, biomedical determinants are examined for 
their contributions to the biological health of disabled people, whereas social determinants are 
rarely examined for their contributions to the biological and social well-being of disabled 
people (Wolbring, 2006). Treating disability is most often seen as a biomedical issue leading 
to its medicalization, in which the appropriate response becomes 'the development of health 
practices designed to reduce or eliminate the creation of people with such impairments' 
(Wasserman, Bickenbach and Wachbroit, 2005, p.  12). 
However, what is disabling is the inflexibility and limitations of the social and physical 
environments and their failure to accommodate perceived individual variety and difference, 
coupled with discriminatory and oppressive attitudes towards and treatment of people with 
impairments (Taylor and Mykitiuk, 2001; Davis, 2002; Shakespeare, 2005; Wasserman, 
Bickenbach and Wachbroit, 2005; Shakespeare, 2006; Thomas, 2007). Having an impair-
ment (or a biomedical condition) in a disabling environment does not mean that one is 
unhealthy, though it may be perceived that way. However, when biomedical differences in 
health arise, such outcomes are more often attributable to biological (and increasingly 
genetic) differences than to systemic disablism. But, even in cases where an individual does 
have a genetic difference or a biomedical anomaly, the material and social environment in 
which that individual lives may be more important in determining that person's health and 
well-being than the genetic difference or anomaly. This situation is due to the fact that 
people with impairments have less access both to health practitioners and to social deter-
minants of health, such as education, employment, transportation and social support 
(Townsend, 1979). Rectifying social and physical challenges requires environmental and 
social justice responses and not individualized biomedical interventions. 
The significance of environments, policies, values and services to determinations of 
disability and health is evidenced in the International Classification of Functioning, 
Disability and Health (ICF), the WHO's 2001 framework for describing and measuring 
disability and health (World Health Organization, 2001). Organized around the broad 
components of body functions (both physiological and psychological) and structure 
(anatomical parts), activities (execution of actions) and participation (involvement in a life 
situation), and environmental factors (World Health Organization, 2001), functioning and 
r





characterizations of the health of children and adults. A distinction must be made between 
social, determinants of embryo health that affect the biomedical health of children and 
biomedical determinants of embryo health that are perceived to enhance the social health of 
children and their parents. The health of embryos, like the health of children and adults, 
will always be an unstable concept reflecting the economic, social and political context 
within which its meaning is constructed. 
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